EQL Pharma Investor Relations

Welcome to EQL Pharma's Investor Pages!

We strive to have an open and proactive dialogue with our shareholders.
Read More

Interim Report Q3 2024/2025

Listen to CEO Axel Schörling present EQL Pharma's latest report.
Interim Report Q3 2024/2025

Press Releases

Year-End Report April 2024 - March 2025

Regulatory

Sales and operating profit growth, significant product acquisition completed, 11 new products, first deal outside Europe and graduation year passed

Se all

EQL Pharma in Short

EQL Pharma is an entrepreneurial pharmaceutical company focusing on simplicity and efficiency at all levels of the value chain in order to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals.
Read more about us

Financial Calendar

Subscribe